Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical measures, radiomics, and genomics offer synergistic value in AI-based prediction of overall survival in patients with glioblastoma

24 May 2022

Abstract excerpt

Multi-omic data, i.e., clinical measures, radiomic, and genetic data, capture multi-faceted tumor characteristics, contributing to a comprehensive patient risk assessment. Here, we investigate the additive value and independent reproducibility of integrated diagnostics in prediction of overall survival (OS) in isocitrate dehydrogenase (IDH)-wildtype GBM patients, by combining conventional and deep learning...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Glioma Diagnosis and Treatment
Share to Medical Imaging Techniques and Applications
Share to Radiomics and Machine Learning in Medical Imaging

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35610333
DOI: 10.1038/s41598-022-12699-z

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical measures, radiomics, and genomics offer synergistic value in AI-based prediction of overall survival in patients with glioblastomaPMID 35610333Read ↗

Multi-Omic Prediction of Overall Survival in Patients With Glioblastoma: Additive and Synergistic Value of Clinical Measures, Radiomics, and GenomicsSemantic proximity Read ↗

Radiomic MRI signature reveals three distinct subtypes of glioblastoma with different clinical and molecular characteristics, offering prognostic value beyond IDH1Semantic proximity Read ↗

Machine Learning Model on Multi-Omics Data Enables Risk Stratification and Identifies Molecular Heterogeneity and Therapeutic Targets in GlioblastomaSemantic proximity Read ↗

Integration of Radiomic and Multi-omic Analyses Predicts Survival of Newly Diagnosed IDH1 Wild-Type GlioblastomaSemantic proximity Read ↗

Biological underpinnings of radiomic magnetic resonance imaging phenotypes for risk stratification in IDH wild-type glioblastomaSemantic proximity Read ↗

Integration of MRI radiomics and germline genetics to predict the IDH mutation status of gliomasSemantic proximity Read ↗

Radiomics for Precision Medicine in GlioblastomaSemantic proximity Read ↗

Imaging phenotypes predict overall survival in glioma more accurate than basic demographic and cell mutation profiles.Semantic proximity Read ↗

Integration of MRI radiomics and germline genetics to predict the IDH mutation status of gliomasSemantic proximity Read ↗

Machine Learning-Based Radiomics for Molecular Subtyping of Gliomas.Semantic proximity Read ↗

Machine learning and radiomic phenotyping of lower grade gliomas: improving survival prediction.Semantic proximity Read ↗

Radiomics-based prediction of multiple gene alteration incorporating mutual genetic information in glioblastoma and grade 4 astrocytoma, IDH-mutant.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.